Digitisation | August 09, 2021
AIkido updates on use of machine learning in drug development orogram
The goal for the project is the identification and optimization of anti-viral compounds.
The goal for the project is the identification and optimization of anti-viral compounds.
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
The transaction is expected to close in the Q4FY22
Advances deployment of mRNA technology across vaccines and therapeutics development
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
It works as an adjunct to standard care based on robust clinical trials
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
Subscribe To Our Newsletter & Stay Updated
